Low molecular weight phospholipases A2 in mammalian brain and neural cells: Roles in functions and dysfunctions

Molecular Neurobiology

Volumn 41, Issue 2-3, 2010, Pages 274-289

  Goracci, Gianfrancesco ^a   Ferrini, Monica ^a   Nardicchi, Vincenza ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Brain; Excitotoxicity; Ischemia; Long term potentiation; Neural cells; Neuritogenesis; Neurodegenerative diseases; Phospholipase A2

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFECTIVE AGENT; CHEC 9; GIB PROTEIN; GIIA PROTEIN; GIIC PROTEIN; GIID PROTEIN; GIIE PROTEIN; GIIF PROTEIN; GIII PROTEIN; GV PROTEIN; GX PROTEIN; GXII PROTEIN; INDOLE DERIVATIVE; INDOXAM; LY 311727; MEINDOXAM; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN; PX 18; RILUZOLE; UNCLASSIFIED DRUG; ISOENZYME;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN TISSUE; BRAIN TUMOR; CELL DEATH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DEGENERATIVE DISEASE; ENZYME ACTIVATION; EXCITOTOXICITY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFLAMMATION; LONG TERM POTENTIATION; MAMMAL; MULTIPLE SCLEROSIS; NERVOUS TISSUE; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; WESTERN BLOTTING; ANIMAL; BIOASSAY; BRAIN; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; GENETICS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR WEIGHT; NERVE CELL; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL ASSAY; BRAIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; ISOENZYMES; MOLECULAR WEIGHT; NEURODEGENERATIVE DISEASES; NEURONS; PHOSPHOLIPASE A2 INHIBITORS; PHOSPHOLIPASES A2; TISSUE DISTRIBUTION;

EID: 77955066644     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12035-010-8108-6     Document Type: Conference Paper

References (177)

1. 2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246-1259
2. 2. Annu Rev Biochem 77:495-520
3. 2. Electrostatically neutral interfacial surface targets zwitterionic membranes. J Biol Chem 277:29086-29093
4. 2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99. Biochemistry 36:3104-3114
5. 2 for interfacial activation. Curr Opin Chem Biol 10:473-479
6. 2. Anal Biochem 269:278-288
7. 2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat 77:235-248
8. Elsbach P, Weiss J (1991) Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol 197:24-31
9. 2 under reduced membrane potential. J Biol Chem 279:37860-37869
10. 2 compared. Biochim Biophys Acta 1440:59-72
11. Yu L, Dennis EA (1991) Thio-based phospholipase assay. Methods Enzymol 197:65-75
12. 2 assays with fluorophore-labeled lipid substrates. Methods Enzymol 197:90-94
13. 2 and platelet-activating factor acetyl-hydrolase assays and in vivo fluorescence imaging. Anal Biochem 276:27-35
14. 2 assay using an intramolecularly quenched pyrene-labeled phospholipid analogue as a substrate. Anal Biochem 170:248-255
15. Farber SA, Pack M, Ho SY, Johnson ID, Wagner DS, Dosch R, Mullins MC, Hendrickson HS, Hendrickson EK, Halpern ME (2001) Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292:1385-1388
16. 2 assay for biochemical and cellular activity measurements. Chem Biol 9:795-803
17. 2 acts on the perinuclear membranes. J Biol Chem 277:9358-9365
18. 2 with apoptotic human T cells: role of heparan sulfate proteoglycans. FASEB J 17:1068-1080
19. 2 (GIIA) mediates apoptotic death during NMDA-receptor activation in rat primary cortical neurons. J Neurochem 112:1574-1583
20. De Caro J, Boudouard M, Bonicel J, Guidoni A, Desnuelle P, Rovery M (1981) Porcine pancreatic lipase. Completion of the primary structure. Biochim Biophys Acta 671:129-138
21. 2 from human pancreatic juice. Biochimie 63:677-684
22. 2 from human pancreas. Biochim Biophys Acta 747:93-99
23. 2 at atomic resolution. Acta Crystallogr D Biol Crystallogr 57:516-526
24. A2 at 1.7A resolution. J Mol Biol 147:97-123
25. 2. EMBO J 14:4123-4131
26. 2 activity. Biochem Pharmacol 64:117-124
27. 2 group IB in brain. Cell Mol Neurobiol 25:1107-1122
28. 2 in the rat retina. J Neurosci Res 77:517-524
29. 2. J Biol Chem 264:5768-5775
30. 2 from synovial fluid in rheumatoid arthritis. J Biochem (Tokyo) 100:1297-1303
31. 2 present in rheumatoid arthritic synovial fluid. J Biol Chem 264:5335-5338
32. 2 at 2.2 A resolution. Nature 352:79-82
33. 2 are expressed in rat brain. Neurosci Lett 258:139-142
34. 2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflam 3:28
35. 2 from rat brain. J Neurochem 73:1278-1287
36. 2: epitope analysis and application in western blotting. Int J Biochem 25:433-439
37. 2 subtypes in rat cerebellum. J Neurocytol 33:297-307
38. 2 enzymes: secretory type IIA and cytosolic type IV. J Neurochem 80:989-997
39. 2 mRNA to meiotic cells in the mouse. J Cell Biochem 64:369-375
40. 2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32:328-333
41. 2. J Biol Chem 274:19152-19160
42. 2s. J Biol Chem 275:5785-5793
43. 2 with homology to the group III bee venom enzyme. J Biol Chem 275:7492-7496
44. 2 promotes neuronal outgrowth and survival. Biochem J 409:429-438
45. Cho W (2000) Structure, function and regulation of group V phospholipase A(2). Biochim Biophys Acta 1488:48-58
46. 2. J Biol Chem 269:2365-2368
47. 2 groups IIE, Vand X in the rat brain. J Neurosci Res 83:874-882
48. 2 in the nuclei of neuronal and glial cells of rat brain cortex. Biochim Biophys Acta 1771:1345-1352
49. 2. J Biol Chem 272:15745-15752
50. 2. J Biol Chem 280:23203-23214
51. 2. J Biol Chem 275:39823-39826
52. 2 in neurological disorders, Springer Science + Business Media, New York.
53. 2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat 8:1-30
54. 2 against Pseudomonas aeruginosa clinical isolates. J Med Microbiol 52:1039-1045
55. 2. Cardiovasc Drugs Ther 23:61-72
56. 2. Review. Biochim Biophys Acta 1781:1-9
57. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266:2647-2651
58. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92:2516-2523
59. 2 expression in rat cultured astrocytes by LPS, TNF alpha and IL-1 beta. Prog Brain Res 105:231-238
60. 2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha and IL-1 beta. Interactive effects. Mol Chem Neuropathol 25:1-17
61. 2). FEBS Lett 410:49-53
62. Kolko M, Nielsen M, Bazan NG, Diemer NH (2002) Secretory phospholipase A(2) induces delayed neuronal COX-2 expression compared with glutamate. J Neurosci Res 69:169-177
63. Choi SH, Langenbach R, Bosetti F (2006) Cyclooxygenase-1 and-2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis. J Neurochem 98:801-811
64. 2 alpha activity that is responsible for arachidonic acid release. J Biol Chem 278:24153-24163
65. Goracci G, Balestrieri ML, Nardicchi V (2009) Metabolism and functions of platelet-activating factor (PAF) in the nervous tissue, in neural lipids pp. 311-352. Springer, New York, USA.
66. Goracci G, Francescangeli E (1991) Properties of PAF-synthesizing phosphocholinetransferase and evidence for lyso-PAF acetyltransferase activity in rat brain. Lipids 26:986-991
67. 2 activity enriched in the nerve growth cone. J Neurochem 67:2599-2608
68. 2s plays a critical role for neurite outgrowth induction in PC12 cells. Brain Res 1015:207-211
69. 2 from snake venoms on survival and neurite outhgrowth in pheochromocytoma cell line PC12. Biochemistry (Mosc) 71:678-684
70. 2 induces neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J Biol Chem 280(30):28044-28052
71. 2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent Fatty Acids 76:47-55
72. 2 in synaptosomes and subsynaptosomal fractions of rat brain. Hoppe Seylers Z Physiol Chem 355:1535-1542
73. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem J 318(Pt 2):701-709
74. 2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons. Neuroscience 121:891-898
75. 2 in brain cortical cultures. Biochem J 310(Pt 1):83-90
76. 2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J Neurosci Res 67:634-645
77. 2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 271:32722-32728
78. 2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res 68:558-567
79. Anwyl R (2009) Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56:735-740
80. Macdonald JF, Jackson MF, Beazely MA (2006) Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 18:71-84
81. Medina JH, Izquierdo I (1995) Retrograde messengers, long-term potentiation and memory. Brain Res Brain Res Rev 21:185-194
82. 2 and release of arachidonic acid and other lipid mediators at the synapse: the role of platelet-activating factor. J Lipid Mediat 6:421-427
83. Dorman RV, Hamm TF, Damron DS, Freeman EJ (1992) Modulation of glutamate release from hippocampal mossy fiber nerve endings by arachidonic acid and eicosanoids. Adv Exp Med Biol 318:121-136
84. Grassi S, Francescangeli E, Goracci G, Pettorossi VE (1998) Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. J Neurophysiol 79:3266-3271
85. Kato K, Clark GD, Bazan NG, Zorumski CF (1994) Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179
86. Lazarewicz JW, Wroblewski JT, Palmer ME, Costa E (1988) Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 27:765-769
87. 2 inhibitor, on the induction and maintenance of LTP in hippocampal slices. Brain Res 537:49-53
88. Miller B, Sarantis M, Traynelis SF, Attwell D (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355 (6362):722-725
89. Pellerin L, Wolfe LS (1991) Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus. Neurochem Res 16:983-989
90. 2. Trends Pharmacol Sci 20:162-170
91. 2 is internalized into motoneuron-like cells where it is rapidly translocated into the cytosol. Biochim Biophys Acta 1783:1129-1139
92. 2, reactive oxygen species and lipid peroxidation in CNS pathologies. BMB Rep 41:560-567
93. 2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45:205-213
94. Ankarcrona M (1998) Glutamate induced cell death: apoptosis or necrosis? Prog Brain Res 116:265-272
95. Nicotera P, Ankarcrona M, Bonfoco E, Orrenius S, Lipton SA (1997) Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv Neurol 72:95-101
96. Mattson MP (2007) Calcium and neurodegeneration. Aging Cell 6:337-350
97. 2, hydroxyl radicals and lipid peroxidation in transient cerebral ischemia. Antioxid Redox Signal 5:647-654
98. Moncada S, Bolanos JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97:1676-1689
99. Murphy AN, Fiskum G, Beal MF (1999) Mitochondria in neurodegeneration: bioenergetic function in cell life and death [Review]. J Cereb Blood Flow Metab 19:231-245
100. 2 in cortical neurons. J Neurochem 106:45-55
101. Peterson B, Stovall K, Monian P, Franklin JL, Cummings BS (2008) Alterations in phospholipid and fatty acid lipid profiles in primary neocortical cells during oxidant-induced cell injury. Chem Biol Interact 174:163-176
102. 2 potentiates glutamate-induced rat striatal neuronal cell death in vivo. Neurosci Lett 274:167-170
103. 2 induces neuronal cell death via apoptosis. Mol Pharmacol 61:114-126
104. 2 induces neuronal cell death via apoptosis. J Neurochem 81:449-461
105. 2-IIA and ROS generation in peripheral mitochondria are critical for neuronal death. Brain Res 1153:43-51
106. 2. FEBS Lett 553:309-314
107. 2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J Biol Chem 281:6931-6939
108. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577-599
109. 2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem 266:9956-9960
110. 2-IIA in astrocytes. Neurochem Int 55:362-368
111. Bazan NG Jr (1970) Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218:1-10
112. 2, reactive oxygen species and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-387
113. Phillis JW, O'Regan MH (2004) A potentially critical role of phospholipases in central nervous system ischemic, traumatic and neurodegenerative disorders. Brain Res Brain Res Rev 44:13-47
114. 2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res 1134:199-205
115. 2) and lipid mediator release in the brain. J Lipid Mediat Cell Signal 14:3-7
116. 2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem 90:637-645
117. 2 in ischemic and toxic brain injury. Neurochem Res 25:745-753
118. 2 inhibition protects against neurovascular injury following experimental stroke in rat. J Neuroinflammation 6:21
119. 2 inhibitor PX-18 in cerebral ischemia/reperfusion in gerbils. Brain Res 1285:188-195
120. Yagami T, Ueda K, Hata S, Kuroda T, Itoh N, Sakaguchi G, Okamura N, Sakaeda T, Fujimoto M (2005) S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis. Neuropharmacology 49:174-184
121. 2 and its involvement in Alzheimer's disease. Biochem Soc Trans 26:243-246
122. 2-generated lipid mediators in the brain: the good, the bad and the ugly. Neuroscientist 12:245-260
123. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3:51-63
124. 2 enzyme. Psychopharma-cology (Berl) 198:1-27
125. 2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neuro-chem 103:1-16
126. 2 activity is increased in Alzheimer disease. Clin Chem 55:2171-2179
127. Bueler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218:235-246
128. Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7:97-109
129. 2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637
130. 2 phosphorylation, arachidonic acid release and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism\the possible key role of PKG J Neurochem 110:307-317
131. 2 of rat brain towards specifically labelled 1, 2-diacyl-, 1-alk-1'-enyl-2-acyl-and 1-alkyl-2-acyl-sn-glycero-3-phosphorylcholine. J Neurochem 23:745-750
132. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, Gudz T, Macklin WB, Lewis DA, Fox RJ, Rudick R, Mirnics K, Trapp BD (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478-489
133. 2 inhibitors suppress central nervous system inflammation. Glia 44:275-282
134. 2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation 3:26
135. 2 superfamily in experimental autoimmune encephalomyelitis. Brain 132:1221-1235
136. 2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41:323-335
137. Koh JY, Kim DK, Hwang JY, Kim YH, Seo JH (1999) Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons. J Neurochem 72:716-723
138. Cudkowicz M E, Katz J, Moore D H, O'neill G, Glass J. D, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott M P and Miller R G (2009) Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Dec 4
139. Vucic S, Cheah BC, Kiernan MC (2009) Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol 220:177-182
140. Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, Golden WC (2007) Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol 500:20-46
141. Martin LJ (2010) The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy. Biochim Biophys Acta 1802:186-197
142. Klussmann S, Martin-Villalba A (2005) Molecular targets in spinal cord injury. J Mol Med 83:657-671
143. Beattie MS, Farooqui AA, Bresnahan JC (2000) Review of current evidence for apoptosis after spinal cord injury. J Neuro-trauma 17:915-925
144. Hall ED, Springer JE (2004) Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1:80-100
145. Murphy EJ, Behrmann D, Bates CM, Horrocks LA (1994) Lipid alterations following impact spinal cord injury in the rat. Mol Chem Neuropathol 23:13-26
146. Liu NK, Zhang YP, Titsworth WL, Jiang X, Han S, Lu PH, Shields CB, Xu XM (2006) A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 59:606-619
147. Titsworth WL, Cheng X, Ke Y, Deng L, Burckardt KA, Pendleton C, Liu NK, Shao H, Cao QL, Xu XM (2009) Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death. Glia 57:1521-1537
148. Cummings BS (2007) Phospholipase A2 as targets for anti-cancer drugs. Biochem Pharmacol 74:949-959
149. Laye JP, Gill JH (2003) Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 8:710-716
150. Menschikowski M, Hagelgans A, Gussakovsky E, Kostka H, Paley EL, Siegert G (2008) Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms. Neoplasia 10:279-286
151. Surrel F, Jemel I, Boilard E, Bollinger JG, Payre C, Mounier CM, Talvinen KA, Laine VJ, Nevalainen TJ, Gelb MH, Lambeau G (2009) Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators. Mol Pharmacol 76:778-790
152. Hernandez M, Burillo SL, Crespo MS, Nieto ML (1998) Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J Biol Chem 273:606-612
153. Martin R, Hernandez M, Ibeas E, Fuentes L, Salicio V, Arnes M, Nieto ML (2009) Secreted phospholipase A2-IIA modulates key regulators of proliferation on astrocytoma cells. J Neurochem 111:988-999
154. Ibeas E, Fuentes L, Martin R, Hernandez M, Nieto ML (2009) Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis. Cardiovasc Res 81:54-63
155. 2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58:591-620
156. 2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49:139-153
157. 2. J Med Chem 51:4708-4714
158. 2. J Biol Chem 277:48535-48549
159. 2. Nat Struct Biol 2:458-465
160. Pilitsis JG, Diaz FG, O'Regan MH, Phillis JW (2002) Differential effects of phospholipase inhibitors on free fatty acid efflux in rat cerebral cortex during ischemia-reperfusion injury. Brain Res 951:96-106
161. 2 inhibitor. J Neurotrauma 21:1683-1691
162. 2 by neuron survival and anti-inflammatory peptide CHEC-9. J Neuroinflammation 3:25
163. Asha DS (2009) Aging brain: prevention of oxidative stress by vitamin E and exercise. Sci World Journal 9:366-372
164. Butterfield DA, Castegna A, Drake J, Scapagnini G, Calabrese V (2002) Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci 5:229-239
165. 2 activity in rat heart myoblastic cells. Biochem J 319:385-391
166. Pentland AP, Morrison AR, Jacobs SC, Hruza LL, Hebert JS, Packer L (1992) Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J Biol Chem 267:15578-15584
167. 2. Chem Phys Lipids 91:109-118
168. 2 and alpha-tocopherol at 1.8 A resolution. J Mol Biol 320:215-222
169. 2 inhibitors. Prostaglandins Leukot Essent Fatty Acids 76:205-212
170. 2 inhibitor PX-18 preserves microvascular reactivity after cerebral ischemia in piglets. Microvasc Res 78:212-217
171. 2 by synthetic peptides derived from the primary sequence. J Biol Chem 271:23992-23998
172. 2 based on native peptide inhibition. J Biol Chem 276:33156-33164
173. Chen H, Chan DC (2009) Mitochondrial dynamics\fusion, fission, movement and mitophagy\in neurodegenerative diseases. Hum Mol Genet 18(R2):R169-R176
174. 2 neurotoxins enter neurons, bind specifically to mitochondria and open their transition pores. J Biol Chem 283:34013-34020
175. 2 into mammalian motor nerve terminals. Exp Neurol 219:591-594
176. 2 in cultured rat astrocytes. J Biol Chem 275:10876-10886
177. 2. J Biol Chem 277:19145-19155